Allergy Partners of North Texas Research

Dallas, Texas 75230

0 studies enrolling now · 7 studies all time

What they study most

Immunologic Deficiency Syndromes, Peanut Allergy, Primary Immune Deficiency, Primary Immunodeficiency, Primary Immunodeficiency Disease, Primary Immunodeficiency Diseases (PID)

Studies at this site

• Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients — Completed
• Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency — Running, not enrolling
• CNP-201 in Subjects With Peanut Allergy — Stopped early
• Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects — Completed
• A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Immune Globulin (Human) 10% (Gamunex-C) PEG Process (IVIG-PEG) Compared to Gamunex-C in Participants With Primary Humoral Immunodeficiency — Completed
• Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency — Completed
• Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE) — Completed